Consejo Superior de Investigaciones Cientificas (CSIC);The Governing Council of the University of Toronto
发明人:
申请号：
EP16789355.1
公开号：
EP3305794A1
申请日:
2016.04.27
申请国别(地区):
EP
年份:
2018
代理人:
摘要：
The present invention relates to a family of chromenopyrazole derivatives of formula (I):which have the ability to modulate the receptor of the cannabinoid family GPR55, whereby the invention also relates to the use of these compounds for the manufacture of a medicament for the treatment of diseases in which the GPR55 receptor has a physiological role such as diabetes, Parkinson's disease, multiple sclerosis, neuropathic pain, osteoporosis and cancers such as cholangiocarcinoma, breast cancer, ovarian and prostate cancer, glioblastoma, and cutaneous carcinoma.
